Format

Send to

Choose Destination
J Neurol. 2017 Feb;264(2):316-326. doi: 10.1007/s00415-016-8334-6. Epub 2016 Nov 28.

Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.

Author information

1
Department of Physical Therapy and Rehabilitation, University of California, San Francisco and San Francisco State University, San Francisco, CA, USA.
2
Department of Neurology, University of California San Francisco, 675 Nelson Rising Lane, Box 3206, San Francisco, CA, 94158, USA.
3
Division of Cardiology, Department of Medicine, University of California, San Francisco, CA, USA.
4
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
5
Department of Neurology, University of California San Francisco, 675 Nelson Rising Lane, Box 3206, San Francisco, CA, 94158, USA. Jeffrey.Gelfand@ucsf.edu.

Abstract

Disability measures in multiple sclerosis (MS) rely heavily on ambulatory function, and current metrics fail to capture potentially important variability in walking behavior. We sought to determine whether remote step count monitoring using a consumer-friendly accelerometer (Fitbit Flex) can enhance MS disability assessment. 99 adults with relapsing or progressive MS able to walk ≥2-min were prospectively recruited. At 4 weeks, study retention was 97% and median Fitbit use was 97% of days. Substudy validation resulted in high interclass correlations between Fitbit, ActiGraph and manual step count tally during a 2-minute walk test, and between Fitbit and ActiGraph (ICC = 0.76) during 7-day home monitoring. Over 4 weeks of continuous monitoring, daily steps were lower in progressive versus relapsing MS (mean difference 2546 steps, p < 0.01). Lower average daily step count was associated with greater disability on the Expanded Disability Status Scale (EDSS) (p < 0.001). Within each EDSS category, substantial variability in step count was apparent (i.e., EDSS = 6.0 range 1097-7152). Step count demonstrated moderate-strong correlations with other walking measures. Lower average daily step count is associated with greater MS disability and captures important variability in real-world walking activity otherwise masked by standard disability scales, including the EDSS. These results support remote step count monitoring as an exploratory outcome in MS trials.

KEYWORDS:

Accelerometer; Multiple sclerosis; Outcome measurement; Progressive; Relapsing; Remote physical activity monitoring

PMID:
27896433
PMCID:
PMC5292081
DOI:
10.1007/s00415-016-8334-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center